These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 20616152)
1. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Vitner EB; Dekel H; Zigdon H; Shachar T; Farfel-Becker T; Eilam R; Karlsson S; Futerman AH Hum Mol Genet; 2010 Sep; 19(18):3583-90. PubMed ID: 20616152 [TBL] [Abstract][Full Text] [Related]
2. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease. Vitner EB; Farfel-Becker T; Eilam R; Biton I; Futerman AH Brain; 2012 Jun; 135(Pt 6):1724-35. PubMed ID: 22566609 [TBL] [Abstract][Full Text] [Related]
3. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Farfel-Becker T; Vitner EB; Pressey SN; Eilam R; Cooper JD; Futerman AH Hum Mol Genet; 2011 Apr; 20(7):1375-86. PubMed ID: 21252206 [TBL] [Abstract][Full Text] [Related]
4. No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease. Farfel-Becker T; Vitner E; Dekel H; Leshem N; Enquist IB; Karlsson S; Futerman AH Hum Mol Genet; 2009 Apr; 18(8):1482-8. PubMed ID: 19193629 [TBL] [Abstract][Full Text] [Related]
5. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues. Nakanishi H; Tominaga K; Amano T; Hirotsu I; Inoue T; Yamamoto K Exp Neurol; 1994 Mar; 126(1):119-28. PubMed ID: 8157122 [TBL] [Abstract][Full Text] [Related]
6. Global gene expression in a type 2 Gaucher disease brain. Myerowitz R; Mizukami H; Richardson KL; Finn LS; Tifft CJ; Proia RL Mol Genet Metab; 2004 Dec; 83(4):288-96. PubMed ID: 15589115 [TBL] [Abstract][Full Text] [Related]
7. Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Pelled D; Trajkovic-Bodennec S; Lloyd-Evans E; Sidransky E; Schiffmann R; Futerman AH Neurobiol Dis; 2005 Feb; 18(1):83-8. PubMed ID: 15649698 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gaucher disease. Kim EY; Hong YB; Go SH; Lee B; Jung SC Exp Mol Med; 2006 Aug; 38(4):348-56. PubMed ID: 16953113 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of the lysosomal protease cathepsin S in hippocampal microglia following kainate-induced seizures. Akahoshi N; Murashima YL; Himi T; Ishizaki Y; Ishii I Neurosci Lett; 2007 Dec; 429(2-3):136-41. PubMed ID: 17997037 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of cathepsins E and D in reactive microglial cells associated with spongiform degeneration in the brain stem of senescence-accelerated mouse. Amano T; Nakanishi H; Oka M; Yamamoto K Exp Neurol; 1995 Dec; 136(2):171-82. PubMed ID: 7498407 [TBL] [Abstract][Full Text] [Related]
11. Neuropathology provides clues to the pathophysiology of Gaucher disease. Wong K; Sidransky E; Verma A; Mixon T; Sandberg GD; Wakefield LK; Morrison A; Lwin A; Colegial C; Allman JM; Schiffmann R Mol Genet Metab; 2004 Jul; 82(3):192-207. PubMed ID: 15234332 [TBL] [Abstract][Full Text] [Related]
16. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Felbor U; Kessler B; Mothes W; Goebel HH; Ploegh HL; Bronson RT; Olsen BR Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7883-8. PubMed ID: 12048238 [TBL] [Abstract][Full Text] [Related]
17. Transient forebrain ischemia induces increased expression and specific localization of cathepsins E and D in rat hippocampus and neostriatum. Nakanishi H; Tsukuba T; Kondou T; Tanaka T; Yamamoto K Exp Neurol; 1993 Jun; 121(2):215-23. PubMed ID: 8339772 [TBL] [Abstract][Full Text] [Related]
18. Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. Orvisky E; Sidransky E; McKinney CE; Lamarca ME; Samimi R; Krasnewich D; Martin BM; Ginns EI Pediatr Res; 2000 Aug; 48(2):233-7. PubMed ID: 10926300 [TBL] [Abstract][Full Text] [Related]
19. Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. Moran MT; Schofield JP; Hayman AR; Shi GP; Young E; Cox TM Blood; 2000 Sep; 96(5):1969-78. PubMed ID: 10961902 [TBL] [Abstract][Full Text] [Related]
20. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking. Sun Y; Witte DP; Zamzow M; Ran H; Quinn B; Matsuda J; Grabowski GA Hum Mol Genet; 2007 Apr; 16(8):957-71. PubMed ID: 17353235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]